Prostate adenoid cystic carcinoma

Summary

Prostate adenoid cystic carcinoma (MONDO:0003177) is a cancer. A subtype of adenoid cystic carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	prostate adenoid cystic carcinoma
Mondo ID	MONDO:0003177
DOID	DOID:4868
NCIT	C5539
UMLS	C1335502
MedGen	233352
GARD	0023399
Anatomy (UBERON)	UBERON:0002367
Is cancer (heuristic)	yes

Also known as: adenoid cystic carcinoma of prostate · adenoid cystic carcinoma of the prostate · prostate adenoid cystic carcinoma · prostate gland adenoid cystic carcinoma

Disease family

This is a subtype of adenoid cystic carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › adenoid cystic carcinoma › prostate adenoid cystic carcinoma

Related subtypes (16): lymph node adenoid cystic carcinoma, salivary gland adenoid cystic carcinoma, cutaneous adenocystic carcinoma, lung adenoid cystic carcinoma, adenoid cystic breast carcinoma, esophageal adenoid cystic carcinoma, Bartholin gland adenoid cystic carcinoma, cervical adenoid cystic carcinoma, lacrimal gland adenoid cystic carcinoma, laryngeal adenoid cystic carcinoma, paranasal sinus adenoid cystic carcinoma, pharyngeal adenoid cystic carcinoma, tracheal adenoid cystic carcinoma, vaginal adenoid cystic carcinoma, adenoid cystic carcinoma of the corpus uteri, adenoid cystic carcinoma of oropharynx

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.